AB-PACLI(paclitaxel protein-bound particles for injectable suspension)
Therapeutic class: microtubule inhibitor
- Metastatic breast cancer, after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated.
- Locally advanced or metastatic non-small cell lung cancer (NSCLC), as first-line treatment in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy.
- Metastatic adenocarcinoma of the pancreas as first-line treatment, in combination with gemcitabine.
100 mg vial
100 mg:-
A lyophilized vial of 100 mg- 20°C to 25°C (68°F to 77°F), Shelf Life: 2 Years
- As directed by physician
